Cargando…

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice

BACKGROUND: Numerous studies indicate an association between neurodegenerative and metabolic diseases. Although still a matter of debate, growing evidence from epidemiological and animal studies indicate that preexisting diabetes increases the risk to develop Parkinson's disease. However, the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez‐Taboada, Iara, Alberquilla, Samuel, Martín, Eduardo D., Anand, Rishi, Vietti‐Michelina, Stefania, Tebeka, Nchimunya N., Cantley, James, Cragg, Stephanie J., Moratalla, Rosario, Vallejo, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818508/
https://www.ncbi.nlm.nih.gov/pubmed/32666590
http://dx.doi.org/10.1002/mds.28124
_version_ 1783638851304030208
author Pérez‐Taboada, Iara
Alberquilla, Samuel
Martín, Eduardo D.
Anand, Rishi
Vietti‐Michelina, Stefania
Tebeka, Nchimunya N.
Cantley, James
Cragg, Stephanie J.
Moratalla, Rosario
Vallejo, Mario
author_facet Pérez‐Taboada, Iara
Alberquilla, Samuel
Martín, Eduardo D.
Anand, Rishi
Vietti‐Michelina, Stefania
Tebeka, Nchimunya N.
Cantley, James
Cragg, Stephanie J.
Moratalla, Rosario
Vallejo, Mario
author_sort Pérez‐Taboada, Iara
collection PubMed
description BACKGROUND: Numerous studies indicate an association between neurodegenerative and metabolic diseases. Although still a matter of debate, growing evidence from epidemiological and animal studies indicate that preexisting diabetes increases the risk to develop Parkinson's disease. However, the mechanisms of such an association are unknown. OBJECTIVES: We investigated whether diabetes alters striatal dopamine neurotransmission and assessed the vulnerability of nigrostriatal neurons to neurodegeneration. METHODS: We used streptozotocin‐treated and genetically diabetic db/db mice. Expression of oxidative stress and nigrostriatal neuronal markers and levels of dopamine and its metabolites were monitored. Dopamine release and uptake were assessed using fast‐scan cyclic voltammetry. 6‐Hydroxydopamine was unilaterally injected into the striatum using stereotaxic surgery. Motor performance was scored using specific tests. RESULTS: Diabetes resulted in oxidative stress and decreased levels of dopamine and its metabolites in the striatum. Levels of proteins regulating dopamine release and uptake, including the dopamine transporter, the Girk2 potassium channel, the vesicular monoamine transporter 2, and the presynaptic vesicle protein synaptobrevin‐2, were decreased in diabetic mice. Electrically evoked levels of extracellular dopamine in the striatum were enhanced, and altered dopamine uptake was observed. Striatal microinjections of a subthreshold dose of the neurotoxin 6‐hydroxydopamine in diabetic mice, insufficient to cause motor alterations in nondiabetic animals, resulted in motor impairment, higher loss of striatal dopaminergic axons, and decreased neuronal cell bodies in the substantia nigra. CONCLUSIONS: Our results indicate that diabetes promotes striatal oxidative stress, alters dopamine neurotransmission, and increases vulnerability to neurodegenerative damage leading to motor impairment. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
format Online
Article
Text
id pubmed-7818508
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78185082021-01-26 Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice Pérez‐Taboada, Iara Alberquilla, Samuel Martín, Eduardo D. Anand, Rishi Vietti‐Michelina, Stefania Tebeka, Nchimunya N. Cantley, James Cragg, Stephanie J. Moratalla, Rosario Vallejo, Mario Mov Disord Regular Issue Articles BACKGROUND: Numerous studies indicate an association between neurodegenerative and metabolic diseases. Although still a matter of debate, growing evidence from epidemiological and animal studies indicate that preexisting diabetes increases the risk to develop Parkinson's disease. However, the mechanisms of such an association are unknown. OBJECTIVES: We investigated whether diabetes alters striatal dopamine neurotransmission and assessed the vulnerability of nigrostriatal neurons to neurodegeneration. METHODS: We used streptozotocin‐treated and genetically diabetic db/db mice. Expression of oxidative stress and nigrostriatal neuronal markers and levels of dopamine and its metabolites were monitored. Dopamine release and uptake were assessed using fast‐scan cyclic voltammetry. 6‐Hydroxydopamine was unilaterally injected into the striatum using stereotaxic surgery. Motor performance was scored using specific tests. RESULTS: Diabetes resulted in oxidative stress and decreased levels of dopamine and its metabolites in the striatum. Levels of proteins regulating dopamine release and uptake, including the dopamine transporter, the Girk2 potassium channel, the vesicular monoamine transporter 2, and the presynaptic vesicle protein synaptobrevin‐2, were decreased in diabetic mice. Electrically evoked levels of extracellular dopamine in the striatum were enhanced, and altered dopamine uptake was observed. Striatal microinjections of a subthreshold dose of the neurotoxin 6‐hydroxydopamine in diabetic mice, insufficient to cause motor alterations in nondiabetic animals, resulted in motor impairment, higher loss of striatal dopaminergic axons, and decreased neuronal cell bodies in the substantia nigra. CONCLUSIONS: Our results indicate that diabetes promotes striatal oxidative stress, alters dopamine neurotransmission, and increases vulnerability to neurodegenerative damage leading to motor impairment. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. John Wiley & Sons, Inc. 2020-07-15 2020-09 /pmc/articles/PMC7818508/ /pubmed/32666590 http://dx.doi.org/10.1002/mds.28124 Text en © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Issue Articles
Pérez‐Taboada, Iara
Alberquilla, Samuel
Martín, Eduardo D.
Anand, Rishi
Vietti‐Michelina, Stefania
Tebeka, Nchimunya N.
Cantley, James
Cragg, Stephanie J.
Moratalla, Rosario
Vallejo, Mario
Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
title Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
title_full Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
title_fullStr Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
title_full_unstemmed Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
title_short Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
title_sort diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice
topic Regular Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818508/
https://www.ncbi.nlm.nih.gov/pubmed/32666590
http://dx.doi.org/10.1002/mds.28124
work_keys_str_mv AT pereztaboadaiara diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT alberquillasamuel diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT martineduardod diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT anandrishi diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT viettimichelinastefania diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT tebekanchimunyan diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT cantleyjames diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT craggstephaniej diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT moratallarosario diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice
AT vallejomario diabetescausesdysfunctionaldopamineneurotransmissionfavoringnigrostriataldegenerationinmice